Benicar Side Effect: Kidney Issues

Posted on July 20, 2016

An approximate 67 million Americans suffer from hypertension, or high blood pressure. This has created a fertile marketplace for pharmaceutical corporations hoping to cash in on a malady that affects so many. Daiichi Sankyo Company, Japan’s second largest pharmaceutical manufacturer, developed a blood pressure medication called Benicar (olmesartan medoxomil) that was approved by the U.S. Food and Drug Administration (FDA) in 2002. But since its FDA approval, many negative side effects have been linked to the use of Benicar, one of the most serious being kidney failure (also referred to as renal failure). The function of the kidneys is to filter waste products from the blood. When the kidneys aren’t functioning properly, the level of waste products in the blood rises. Higher levels of waste in one’s blood can be potentially fatal. Patients who have been treated with Benicar are advised to watch out for symptoms of kidney failure, including the following:

  • Decreased Urine Output (Oliguria)
  • Fluid retention that causes swelling in the legs, ankles, and feet
  • Drowsiness
  • Shortness of breath
  • Fatigue
  • Mental confusion and seizures
  • Nausea and vomiting
  • Chest pain or pressure

Patients experiencing any of these symptoms are urged to notify their physician.

If you have been treated with Benicar and have experienced any side effects, you may be entitled to compensation for medical bills, pain and suffering, lost wages, and more. But filing a successful claim against a pharmaceutical giant like the Daiichi Sankyo Company is no easy task. To win a claim against such a company requires skilled representation by a Benicar injury attorney. The legal team at the law offices of Farah & Farah has been successfully representing injury victims for over 35 years and can get you the settlement you deserve. Call 1(800) 533-3555 for a free consultation.

  • This field is for validation purposes and should be left unchanged.